May 8 |
Immunome to Present at 2024 Bank of America Healthcare Conference
|
May 2 |
Immunome Appoints Kinney Horn as Chief Business Officer
|
Apr 26 |
Analysts Estimate Immunome, Inc. (IMNM) to Report a Decline in Earnings: What to Look Out for
|
Apr 25 |
Immunome Appoints Sandra M. Swain to Board of Directors
|
Apr 5 |
Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting
|
Apr 4 |
New Strong Sell Stocks for April 4th
|
Apr 3 |
Immunome files to sell 2.18M common shares for holders
|
Apr 2 |
Immunome: An Oncology Powerhouse In The Making
|
Mar 28 |
Immunome GAAP EPS of -$5.38
|
Mar 28 |
Immunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assets
|